-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 R5dJI4PJDf9OIGB9HOyvKy6NRKJ94jRabEQKdvD3tQryToE1GdMq/iGklk2jgIKy
 DWxth6GqAjaAWiEISEODUg==

<SEC-DOCUMENT>0001144204-08-051163.txt : 20080904
<SEC-HEADER>0001144204-08-051163.hdr.sgml : 20080904
<ACCEPTANCE-DATETIME>20080904121136
ACCESSION NUMBER:		0001144204-08-051163
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080827
FILED AS OF DATE:		20080904
DATE AS OF CHANGE:		20080904

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XTL BIOPHARMACEUTICALS LTD
		CENTRAL INDEX KEY:			0001023549
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	BUSINESS ADDRESS:	
		STREET 1:		711 EXECUTIVE BOULEVARD
		STREET 2:		SUITE Q
		CITY:			VALLEY COTTAGE
		STATE:			NY
		ZIP:			10989
		BUSINESS PHONE:		972-8-930-4440

	MAIL ADDRESS:	
		STREET 1:		711 EXECUTIVE BOULEVARD
		STREET 2:		SUITE Q
		CITY:			VALLEY COTTAGE
		STATE:			NY
		ZIP:			10989

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			WEINER BEN-ZION
		CENTRAL INDEX KEY:			0001444400

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51310
		FILM NUMBER:		081055769

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		8452670707

	MAIL ADDRESS:	
		STREET 1:		C/O XTL BIOPHARMACEUTICALS LTD, 711
		CITY:			EXECUTIVE BLVD., SUITE Q
		STATE:			NY
		ZIP:			10989
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>v125173_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0203</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2008-08-27</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001023549</issuerCik>
        <issuerName>XTL BIOPHARMACEUTICALS LTD</issuerName>
        <issuerTradingSymbol>XTLB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001444400</rptOwnerCik>
            <rptOwnerName>WEINER BEN-ZION</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O XTL BIOPHARMACEUTICALS LTD,</rptOwnerStreet1>
            <rptOwnerStreet2>711 EXECUTIVE BLVD., SUITE Q</rptOwnerStreet2>
            <rptOwnerCity>VALLEY COTTAGE</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10989</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>OPTIONS TO PURCHASE ORDINARY SHARES</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2000000</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
        <nonDerivativeHolding>
            <securityTitle>
                <value>ORDINARY SHARES</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>50000</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Options to purchase ordinary shares which vest upon achievement of certain market capitalization based milestones (1/3 upon
 the achievement of $150 million market capitalization, 1/3 upon the achievement of $250 million market capitalization, and
 1/3 upon the achievement of $350 million market capitalization, in each case as set out in the option agreement under which
 Dr. Weiner was granted the options). As of the filing date, 666,667 options have vested.</footnote>
        <footnote id="F2">On August 27, 2008, Mr. Weiner purchased 50,000 ordinary shares at an average price of NIS 1.546 (equivalent to $0.433USD)
 per share on the Tel Aviv Stock Exchange.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Ben-Zion Weiner</signatureName>
        <signatureDate>2008-08-29</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
